Fertility Preservation Option in Young Women with Ovarian Cancer
Authors:
- 19 May 2016
- journal article
- review article
- Published by Taylor & Francis in Future Oncology
- Vol. 12 (14) , 1695-1698
Abstract
No abstract availableKeywords
Funding Information
- Center for Reproductive Health After Disease (P50HD076188)
- Ministry of Health & Welfare, Republic of Korea (HI12C0055)
This publication has 21 references indexed in Scilit:
- Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals of Oncology, 2013
- Effects of Amifostine in Combination With Cyclophosphamide on Female Reproductive SystemReproductive Sciences, 2012
- Activation of dormant ovarian follicles to generate mature eggsProceedings of the National Academy of Sciences, 2010
- Inhibition of the c-Abl–TAp63 pathway protects mouse oocytes from chemotherapy-induced deathNature Medicine, 2009
- Fertility preservation in young women with epithelial ovarian cancerCancer, 2009
- p63 protects the female germ line during meiotic arrestNature, 2006
- Differential expression of p63 isoforms in female reproductive organsMechanisms of Development, 2005
- Predicting age of ovarian failure after radiation to a field that includes the ovariesInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2005
- Cellular processing of platinum anticancer drugsNature Reviews Drug Discovery, 2005
- Binding of the antitumor drug cis-diamminedichloroplatinum(II) (cisplatin) to DNABiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1985